Europe, Middle East & Africa
A better way to navigate potential disruption.
Understanding what will happen, and when, is key to managing the impact of patent expiry - both within your own portfolio and in your competitors’. Stay ahead of potential disruption.
Contact Us Limit surprise, and be ready for change
The impact of patent expiry can be an unsettling prospect. It can change the balance of your portfolio, open up new competition in the form of generics, and shift your market strategy around the world.
Patent intelligence solutions from IQVIA deliver the data and analytics you need. Backed by data on thousands of patent families for both small molecule and biologics, and include in-depth analysis of patents, data exclusivity, and extensions, our team is ready to help you
- Find and assess drug patent expires by country
- Prepare for the entry of generics across markets
- Track ongoing litigation
- Continually model impact scenarios for your brand
IQVIA's Unparalleled Data Assets
60K patent families
tracked across 130 countriesIQVIA's Unparalleled Data Assets
2,500+ molecules
Small molecules covered with in-depth analysis of patents, data exclusivity, and extensionsIQVIA's Unparalleled Data Assets
700+ biologics
covered with in-depth analysis of patents, data exclusivity and extensionsIQVIA's Unparalleled Data Assets
34K+ patents extensions
and supplementary protection certificates referencedIQVIA's Unparalleled Data Assets
8,500+ cases
in litigation analyzedArk Patent Intelligence—Worldwide Pharmaceutical Patent Information
Newsletter
INNsight Newsletter
Get monthly updates on patent protection, new product development, disease forecasts, industry deals and more.
Our latest thinking related to patent intelligence
Related Solutions
